EXAS
EXACT Sciences Corporation
NASDAQ: EXAS · HEALTHCARE · DIAGNOSTICS & RESEARCH
$104.91
+0.00% today
Updated 2026-03-24
Market cap
$20.03B
P/E ratio
—
P/S ratio
6.17x
EPS (TTM)
$-1.10
Dividend yield
—
52W range
$39 – $1,878
Volume
2.7M
WallStSmart proprietary scores
32
out of 100
Grade: F
Strong Sell
Investment rating
6.7
Growth
B5.3
Quality
C+2.0
Profitability
F5.0
Valuation
C+4/9
Piotroski F-Score
Moderate
0.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$106.30
+1.32%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy1 Buy20 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $120.45M — positive
+ Revenue growth 23.10% QoQ
Risks
- Altman Z 0.01 — distress zone
- Thin margins at -6.40%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.08B | $2.50B | $2.76B | $3.25B | $3.25B |
| Net income | $-623.51M | $-204.15M | $-1.03B | $-207.95M | $-85.95M |
| EPS | — | — | — | — | $-1.10 |
| Free cash flow | $-438.02M | $31.93M | $74.55M | $356.78M | $120.45M |
| Profit margin | -29.91% | -8.17% | -37.29% | -6.40% | -6.40% |
Peer comparison
Smart narrative
EXACT Sciences Corporation trades at $104.91. Our Smart Value Score of 32/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 0.01, it sits in the distress. TTM revenue stands at $3.25B. with profit margins at -6.40%.
Frequently asked questions
What is EXACT Sciences Corporation's stock price?
EXACT Sciences Corporation (EXAS) trades at $104.91.
Is EXACT Sciences Corporation overvalued?
Smart Value Score 32/100 (Grade F, Strong Sell).
What is the price target of EXACT Sciences Corporation (EXAS)?
The analyst target price is $106.30, representing +1.3% upside from the current price of $104.91.
What is EXACT Sciences Corporation's revenue?
TTM revenue is $3.25B.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
0.01 — distress.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio6.17x
ROE-8.66%
Beta1.44
50D MA$103.02
200D MA$74.29
Shares out0.19B
Float0.19B
Short ratio—
Avg volume2.7M
Performance
1 week+0.00%
1 month+0.00%
3 months+2.51%
YTD+3.30%
1 year—
3 years—
5 years—